perindopril erbumine 8 MG Oral Tablet
perindopril erbumine
RxCUI: 854925
What the CMS Formulary Data Shows for perindopril erbumine 8 MG Oral Tablet
Per the CMS 2026 Part D formulary file, perindopril erbumine 8 MG Oral Tablet (RxNorm concept RXCUI 854925, generic name perindopril erbumine) appears on 319 distinct formulary files spanning 4,864 Medicare Part D plan offerings - 96% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.4.
Real-world access to perindopril erbumine 8 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,136 Part D beneficiaries filled perindopril erbumine 8 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $1,328,152 and an average per-beneficiary annual cost of $258.60. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry perindopril erbumine 8 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 319
- Plans covering
- 4,864
- Coverage rate
- 96%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,136
- Total spending
- $1,328,152
- Avg per beneficiary
- $258.60
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering perindopril erbumine 8 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is perindopril erbumine 8 MG Oral Tablet covered by Medicare Part D?
Yes, perindopril erbumine 8 MG Oral Tablet is covered by 4,864 Medicare Part D plans (96% of all Part D formularies).
What tier is perindopril erbumine 8 MG Oral Tablet on Medicare Part D plans?
perindopril erbumine 8 MG Oral Tablet averages Tier 2.4 across Part D plans, ranging from Tier 1 to Tier 6.
Does perindopril erbumine 8 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for perindopril erbumine 8 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0.9%.
How much does Medicare spend on perindopril erbumine 8 MG Oral Tablet?
In 2023, total Medicare Part D spending on perindopril erbumine 8 MG Oral Tablet was $1,328,152, covering 5,136 beneficiaries. The average spend per beneficiary was $258.60.
Read our methodology - how this data is sourced, computed, and verified.